Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
FOXO4-DRI: Senolytic Peptide Mechanism and the p53-FOXO4 Axis FOXO4-DRI is a D-retro-inverso peptide that selectively kills senescent cells by disrupting the protective FOXO4-p53 interaction
Accredited Fields: HPLC, GC-FID, GC-MS, ICP-MS, LC-MS/MS, Karl Fischer Titration, Polarimetry, UV-Vis Spectrophotometry, FT-IR, Bacterial Endotoxin Testing (LAL), Sterility Testing, Microbial Limits, Particle Size Analysis (Laser Diffraction), DSC/TGA Thermal Analysis Accreditation Date:2023-09-01 Valid Until:2027-08-31 CNAS : CNAS-A1311 NMPA National Medical Products Administration (NMPA) Drug Manufacturing License License No.: 2852252024732 : : : : 572120 : Scope: APIs (Chemically Synthesized Peptides, Chemical APIs), Pharmaceutical Excipients Issue Date:2024-01-10 Valid Until:2029-01-09 : Certificate Verification Scan QR code or visit SHA-256: 8a71e6d709848865
We designed our memberships to help you save on all of your services, making maintaining your well-being over the years simple and affordable
Meng et al., 2014
When talking about treating forehead wrinkles and frown lines, using anti-aging treatments that are focused on stimulating collagen and elastin (like microneedling and laser skin rejuvenation) will not address the root cause of the wrinkles
The phenomenon has a name precisely because so many people experience it and recover from it
